The Claim
PCSK9 promotes atherosclerosis through low-density lipoprotein (LDL) cholesterol-independent mechanisms by increasing scavenger receptor expression (particularly LOX-1) in macrophages and vascular smooth muscle cells, enhancing oxidized LDL uptake, inhibiting cholesterol efflux via downregulation of ABCA1 and SR-BI, stimulating pro-inflammatory cytokine production through NF-κB activation, and promoting endothelial dysfunction and vascular inflammation.
What the research says
Roughly balanced
Support and challenge are close. The picture may shift as more studies come in.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
PCSK9 doesn't just raise bad cholesterol — it also directly worsens artery disease by making immune and blood vessel cells absorb more damaged fats, reducing their ability to clean out cholesterol, and increasing inflammation in the arteries.
See the scientific wording
PCSK9 promotes atherosclerosis through LDL cholesterol-independent mechanisms, including increasing expression of scavenger receptors (especially LOX-1) in macrophages and vascular smooth muscle cells, enhancing oxidized LDL uptake, inhibiting cholesterol efflux via downregulation of ABCA1 and SR-BI, stimulating pro-inflammatory cytokine production through NF-κB activation, and promoting endothelial dysfunction and vascular inflammation.
What the research says
1 studyThe study says PCSK9 can harm blood vessels in ways that aren't just about raising bad cholesterol, which matches the claim.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.